NYSE ARCA | ETF
The fund will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents as well as in securities not included in the index, but which BFA believes will help the fund track the index.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 5.06% |
| ARWR | Arrowhead Pharmaceuticals Inc | Healthcare | Biotechnology | 4.61% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.57% |
| XENE | Xenon Pharmaceuticals Inc | Healthcare | Biotechnology | 4.53% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 4.40% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 4.29% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.28% |
| CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 4.05% |
| SRRK | Scholar Rock Holding Corp | Healthcare | Biotechnology | 3.98% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 3.95% |
| ARGX | argenx NV ADR | Healthcare | Biotechnology | 3.94% |
| CNTA | Centessa Pharmaceuticals PLC ADR | Healthcare | Biotechnology | 3.91% |
| PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.77% |
| AXNX | Axonics Modulation Technologies Inc | Healthcare | Medical Devices | 3.69% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.68% |
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 3.66% |
| CPRX | Catalyst Pharmaceuticals Inc | Healthcare | Biotechnology | 3.60% |
| ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 3.36% |
| DNTH | Dianthus Therapeutics Inc. | Healthcare | Biotechnology | 3.29% |
| DNLI | Denali Therapeutics Inc | Healthcare | Biotechnology | 2.87% |